New House Bill Seeks To Modernise Dietary Supplement Rules And Reshape FDA Drug Preclusion Framework
Congresswoman Diana Harshbarger (R-TN) introduced H.R. 10336, the Dietary Supplement Innovation Act, on September 10, 2026, targeting long-standing regulatory friction between pharmaceutical and supplement industries. The bill aims to modernise the FDA’s
